top of page
  • Writer's pictureARQon

Europe - Mar 2019

  • EU: More advisory documents issued to support implementation of MDR and IVDR

  • EU: Manual on borderline and classification issues updated

  • EU: New form for medical device incident reporting by manufacturers

  • Serbia: Registration requirements, wholesale dealing and manufacturer obligations covered by new legislation

  • Serbia: New ‘Law on Medical Devices’ fully implemented; electronic submissions now accepted

  • Spain: Clinical investigations involving CE marked devices may now be notified to AEMPS electronically

  • Spain: Launch of national registry of pacemakers and ICDs

  • UK: MHRA issues guidance and drafts contingency legislation for a no deal scenario

  • UK: Guidance updated on leadless cardiac pacemaker therapy

Click here for the full article on Global Regulatory Press.

Contact us at info@arqon.com.


30 views0 comments

Recent Posts

See All

Europe - May 2020

Denmark: New rules mean non-serious adverse events may also need to be reported EU: Application of Regulation (EU) 2017/745 postponed by one year EU: Continued use of lead as a thermal stabiliser in P

EU: MDR delayed to 26 May 2021

Application of the Medical Devices Regulation (MDR) has been deferred by one year, until 26 May 2021, for fear of shortage or delay in getting essential medical devices needed to combat Covid-19. The

EU 2020 MDR Guidance Notes For Class I Manufacturers

There will be no transition period for Class I medical devices which remain in Class I under MDR. From 26th May 2020 onwards, the conformity for Class I medical devices which are not subject to up-cla

bottom of page